SURUNKALI MIYA ISHEMIYASIDA UYQU BUZILISHINING KOGNITIV FUNKTSIYALARGA TA'SIRI VA UNI KORREKSIYASI
##article.subject##:
uyqu buzilishi, kognitiv buzilishlar, kognitiv uyg'otuvchi potentsial, surunkali miya ishemiyasi, melatonin##article.abstract##
Surunkali miya ishemiyasi (SMI) serebrovaskulyar kasalliklarning deyarli 2/3 qismini tashkil qiladi va kognitiv buzilishlarni keltirib chiqaradi. Maqolamizda biz uyqu buzilishlarining kognitiv funktsiyalarga ta'sirini o'rgandik. Bemorlar uyqu buzilishlarini tuzatish uchun melatonin preparatini qabul qilishdi. SMI bilan kasallangan 63 bemor tekshirildi. Bemorlarning o'rtacha yoshi 58,5, 1,4 yoshni tashkil etdi. Bemorlar uyqu buzilishining mavjudligi va surunkali miya ishemiyasi kasalligining bosqichiga qarab 6 guruhga bo'lingan. Uyquning buzilishi va kognitiv buzilish maxsus anketalar yordamida baholandi; bundan tashqari, P300 ning kognitiv potentsiallari o'rganildi. SMI bosqichining oshishi bilan kognitiv ko'rsatkichlar P300 kognitiv uyg'otadigan potentsiallarning tarozi va parametrlariga muvofiq yomonlashdi. Uyqu buzilishi bo'lgan bemorlarda SMIning ko'payishi bilan Epvort shkalasi bo'yicha uyqu parametrlarini yomonlashtirish tendentsiyasi mavjud edi. SMI bilan og'rigan bemorlarda uyqu buzilishi kognitiv funktsiyalarni yomonlashtiradi. SMI bilan og'rigan bemorlarda melatonin bilan davolashda uyqu buzilishi ham, kognitiv buzilish ham yaxshilandi.
Библиографические ссылки
Antipenko E.A. Chronic ischemia of the brain: PhD thesis Sciences. dis. Nizhny Novgorod. 2015: 25
Wayne, A.M. Sleep apnea syndrome and other sleep-related breathing disorders: clinic, diagnosis, treatment / A.M. Wayne, T.S. Eligulashvili, M.G. Poluektov // St. Petersburg: Eidos media. 2002:310.,
Gnezditsky V.V. Evoked potentials of the brain in clinical practice. Moscow, 2011. 264 p.
Gnezditsky V.V., Shamshinova A.M. Experience in the use of evoked potentials in clinical practice. Moscow, 2001. 480 p.
Gordeev S.A. Application of the method of endogenous P300 event-related brain potentials for the study of cognitive functions in normal and clinical practice. Fiziol. person. 2007. (2). 121–133.
Guseva, E.I. Neurology: national leadership / E.I. Guseva, A.N. Konovalova, V.I. Skvortsova and others //M.: GEOTAR-Media. 2010;1040.
Zenkov L.R., Ronkin M.A. Functional diagnosis of nervous diseases. Moscow, 2004. 480 p.
Levina, Ya.I. Insomnia, modern diagnostic and therapeutic approaches / Ed. ME AND. Levin. Moscow: Medpraktika. 2005; 115
Maltseva, A. A., Influence of sleep disorders on cognitive functions in students, 76th scientific conference of students and postgraduate students of the Belarusian State University [Electronic resource]: materials of the conference. At 3 p.m. Part 1, Minsk, May 13–24, 2019 / Belorus. state un-t; editorial board: V. G. Safonov (prev.) [and others]. - Minsk: BSU, 2019. - S. 332-335. https://elib.bsu.by/handle/123456789/232634,
Poluektov M. G., Preobrazhenskaya Irina Sergeevna Sleep disorders and cognitive functions, approaches to therapy // Neurology, neuropsychiatry, psychosomatics. 2014. No. 1.,11. Ally В.A., Jones G.E., Cole J.A., Budson A.E. The P300 component in patients with Alzheimer’s disease and their biological children // Biol. Psychol. 2006. 72. 180–187.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fifth. Arlington, VA: American Psychiatric Association. 2013
Geroldi C., Ferrucci L., Bandinelli S. et al. Mild cognitive deterioration with subcortical features. Prevalence, clinical characteristics, and association with cardiovascular risk factors in community-dwelling older persons (The InCHIANTI Study) // J. Am. Ger. Soc. 2003. 51. 1064–1071.
Johns, M.W. New method for measuring daytime sleepiness: the Epworth sleepiness scale // Sleep. 1991; V.14: №6: 540–545
Johns, M.W. Daytime sleepiness, snoring, and obstructive sleep apnea. The Epworth Sleepiness Scale / M.W. Johns //Chest. 1993; V.103: №1: 30–36. 70.
Meyer J.S., Xu G., Thornby J. et al. Is mild cognitive impairment prodromal for vascular dementia like Alzheimer’s disease? // Stroke. 2002. 33. 1981–1985.
Mild cognitive impairment with subcortical vascular features. Clinical characteristics and outcome // J. Neurol. 2002. 249. 1423–1432.
Morin, C.M. Epidemiology of insomnia: prevalence, self-helptreatments, consultations, and determinants of help-seeking behaviors / C.M. Morin, M. LeBlanc, M. Daley, J.P. Gregoire, C. Mérette // Sleep Med. 2006; 7(2): 123–130.
Nasreddine, Z.S. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment / Z.S. Nasreddine, N.A. Phillips, V. Bédirian, S. Charbonneau, V. Whitehead, I. Collin, J.L. Cummings, H. Chertkow // Am Geriatr Soc.2005; 53(4): 695-9. PMID: 15817019.
Newman, A.B. Relationship of sleep-disordered breathing to cardiovascular risk factors. The Sleep Heart Health Study. Am / A.B. Newman, F.J. Nieto, U. Guidry et al. // Epidemiol. 2001; 154: 50–59.,
Parra, Mario & Ascencio, Lindsay & Urquina, Hugo & Manes, Facundo & Ibanez, Agustin. (2012). P300 and Neuropsychological Assessment in Mild Cognitive Impairment and Alzheimer Dementia. Frontiers in neurology. 3. 172. 10.3389/fneur.2012.00172
Stephens S., Kenny R.A., Rowan E. et al. Association between mild vascular cognitive impairment and impaired activities of daily living in older stroke survivors without dementia // J. Am. Ger. Soc. 2005. 53. (1). 103–10
www.who.int/ru/news/item/30-09-2015-who-number-of-people-over-60-years-set-to-double-by-2050-major-societal-changes-required
Knutson E., Van Cauter P., Zee K.L., Lauderdale D.S. Cross-Sectional Associations between Measures of Sleep and Markers of Glucose Metabolism among Subjects With and Without Diabetes: The Coronary Artery Risk Development in Young Adults (CARDIA) Sleep Study. Diabetes Care 2011; 34: 5: 1171. ,
Гончарова А.Г. Полифункциональное мониторирование в экспертизе состояния здоровья лиц экстремальных профессий. Материалы 6-го Международного научно-практического конгресса «Человек в экстремальных условиях: человеческий фактор и профессиональное здоровье». М 2008; 148—149.
Liu Y., Tanaka H. Overtime work, insufficient sleep, and risk of non-fatal acute myocardial infarction in Japanese men. Occup Environ Med 2002; 59: 447—451.
Poluektov M.G., Levin Y. Results of a Russian multicenter open observational non - comparable study of the efficacy and safety of the Melaxen device (melatonin) for the treatment of sleep apnea (insomnia) in patients with chronic cerebral vascular insufficiency. Journal of Neurology and Psychiatry. S.S. Korsakov 2012; 9:26–31.
Nasreddine, Z.S. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment / Z.S. Nasreddine, N.A. Phillips, V. Bédirian, S. Charbonneau, V. Whitehead, I. Collin, J.L. Cummings, H. Chertkow // Am Geriatr Soc.2005; 53(4): 695-9. PMID: 15817019.
